- Open Access
Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner
Journal of Experimental & Clinical Cancer Research volume 40, Article number: 366 (2021)
Correction to: J Exp Clin Cancer Res 37, 260 (2018)
Following publication of the original article , the authors identified minor errors in Fig. 5; specifically, in Fig. 5c, the label ‘Tumor free (%)’ was used. The correct label is ‘Tumor-bearing mice (%)’. The corrected figure is provided here; the figure caption has been corrected to reflect the same.
In addition, the Competing Interests section of the article has been corrected as follows:
Guoxi Zhang is an employee of Nanjing Luye Pharmaceutical Co., Ltd (Nanjing, China) and provided the main research subject (Lentinan) of the study. The other authors declare that they have no competing interests.
The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.
Deng S, Zhang G, Kuai J, et al. Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. J Exp Clin Cancer Res. 2018;37:260 https://doi.org/10.1186/s13046-018-0932-y.
About this article
Cite this article
Deng, S., Zhang, G., Kuai, J. et al. Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. J Exp Clin Cancer Res 40, 366 (2021). https://doi.org/10.1186/s13046-021-02170-8